The anticonvulsant actions of σ receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices

British Journal of Pharmacology

Volumn 124, Issue 5, 1998, Pages 917-929

  Thurgur, Claire ^a   Church, John ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anticonvulsant activity; Hippocampal slice; N methyl D aspartate (NMDA) receptor; Voltage activated Ca2+ channel; receptor

Indexed keywords

CARAMIPHEN; DEXTROMETHORPHAN; DEXTRORPHAN; IFENPRODIL; LOPERAMIDE; OPIPRAMOL; PENTOXYVERINE; ROPIZINE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN SLICE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031839120     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701902     Document Type: Article

References (65)

1. AITKEN, P.G. (1985). Kainic acid and penicillin: Differential effects on excitatory and inhibitory interactions in the CAI region of the hippocampal slice. Brain Res., 325, 261-269.
2. ALBERTSON, T.E., WALBY, W.F. & JOY, R.M. (1992). Modification of GABA-mediated inhibition by various injectable anesthetics. Anesthesiology, 77, 488-499.
3. ALGER, B.E. & NICOLL, R.A (1982). Feed-forward dendritic inhibition in rat hippocampal pyramidal cells studied in vitro. J. Physiol., 328, 105-23.
4. ANDERSON, W.W., SWARTZWELDER, H.S. & WILSON, W.A (1987). The NMDA receptor antagonist 2-amino-5-phosphonovalerate blocks stimulus train-induced epileptogenesis but not epileptic form bursting in the rat hippocampal slice. J. Neurophysiol., 57, 1-21.
5. ANNELS, S.J., ELLIS, Y. & DAVIES, J.A. (1991). Non-opioid antitussives inhibit endogenous glutamate release from rabbit hippocampal slices. Brain Res., 564, 341-343.
6. APLAND, J.P. & BRAITMAN, D.J. (1990). Effects of non-opioid antitussives on epileptiform activity and NMDA responses in hippocampal and olfactory cortex slices. Brain Res., 529, 277-285.
7. APLAND, J.P. &. CANN, F.J. (1995). Anticonvulsant effects of memantine and MK-801 in guinea pig hippocampal slices. Brain Res. Bull., 37, 311-316.
8. ARAM, J.A., MARTIN, D., TOMCZYK, M., ZEMAN, S., MILLAR, J., POHLER, G. & LODGE, D. (1989). Neocortical epileptogenesis in vitro: Studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J. Pharmacol. Exp. Ther., 248, 320-328.
9. ARYANPUR, J., COLE, A.E., ECCLES, C.U. & FISHER, R.S. (1990). Biphasic action of dextrorphan on penicillin induced bursting in rat hippocampal slice. Brain Res., 519, 65-72.
10. 2 channels and in gerbil global cerebral ischaemia. Eur. J. Pharmacol., 299, 103-112.
11. BINGMANN, D. & SPECKMANN, F.-J. (1989). Specific suppression of pentylenetetrazol-induced epileptiform discharges in CA3 neurons (hippocampal slice, guinea pig) by the organic calcium antagonists flunarizine and verapamil. Exp. Brain Res., 74, 239-248.
12. 2+ channels in rat and mouse cultured hippocampal pyramidal neurones. Br. J. Pharmacol., 116, 2801-2810.
13. CHURCH, J. & MCLENNAN, H. (1989). Electrophysiological properties of rat CA1 pyramidal neurones in vitro modified by changes in extracellular bicarbonate. J Physiol., 415, 85-108.
14. CHURCH, J., FLETCHER, E.J., ABDEL-HAMID, K. & MACDONALD, J.F. (1994a). Loperamide blocks high-voltage-activated calcium channels and N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons. Mol. Pharmacol., 45, 747-757.
15. 2+ channels in rat and mouse cultured hippocampal pyramidal neurones: Comparison with N-methyl-D-aspartate receptor antagonist actions. Br. J. Pharmacol., 113, 499-507.
16. CHURCH, J., JONES, M.G., DAVIES, S.N. & LODGE, D. (1989). Antitussive agents as N-methylaspartate antagonists: Further studies. Can. J. Physiol. Pharmacol., 67, 561-567.
17. CHURCH, J. & LODGE, D. (1990). Anticonvulsant actions of phencyclidine receptor ligands: Correlation with N-methylaspartate antagonism in vivo. Gen. Pharmacol., 21, 165-170.
18. COLE, A.E., ECCLES, C.U., ARYANPUR, J.J. & FISHER, R.S. (1989). Selective depression of N-methyl-D-aspartate-mediated responses by dextrorphan in the hippocampal slice in rat. Neuropharmacology, 28, 249-254.
19. COUSIN, M.A., NICHOLLS, D.G. & POCOCK, J.M. (1993). Flunarizine inhibits both calcium-dependent and -independent release of glutamate from synaptosomes and cultured neurones. Brain Res., 606, 227-236.
20. DEBANNE, D., GUERINEAU, N.C., GÄHWILER, B.H. & THOMPSON, S.M. (1996). Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. J. Physiol., 491, 163-176.
21. DESARRO, G., DESARRO, A., FEDERICO, F. & MELDRUM, B.S. (1990). Anticonvulsant properties of some calcium antagonists on sound-induced seizures in genetically epilepsy prone rats. Gen. Pharmacol., 21, 769-778.
22. DICKIE, B.G.M. & DAVIES, J.A. (1992). Calcium channel blocking agents and potassium-stimulated release of glutamate from cerebellar slices. Eur. J. Phamacol., 229, 97-99.
23. DINGLEDINE, R., HYNES, M.A. & KING, G.L. (1986). Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J. Physiol., 380, 175-189.
24. DUNWIDDIE, T.V. & HAAS, H.L. (1985). Adenosine increases synaptic facilitation in the in vitro rat hippocampus: Evidence for a presynaptic site of action. J. Physiol., 369, 365-377.
25. ELLIS, Y. & DAVIES, J.A. (1994). The effects of sigma ligands on the release of glutamate from rat striatal slices. Naunyn-Schmiedeherg's Arch. Pharmacol., 350, 143-148.
26. FLETCHER, E.J., CHURCH, J., ABDEL-HAMID, K. & MACDONALD, J.F. (1995). Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurones. Br. J. Pharmacol., 116, 2791-2800.
27. FLETCHER, E.J., DREW, C., LODGE, D. & O'SHAUGHNESSY, C.T. (1989). Efflux of rubidium in rat cortical synaptosomes is blocked by sigma and dextromethorphan binding site ligands. Neuropharmacology, 28, 661-666.
28. + channel openers decrease seizures in genetically epileptic rats. Eur. J. Pharmacol., 167, 181-183.
29. HARRIS, E.W. & COTMAN, C.W. (1983). Effects of acidic amino acid antagonists on paired-pulse potentiation at the lateral perforant path. Exp. Brain. Res., 52, 455-460.
30. + mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J. Pharmacol. Exp. Ther., 275, 207-214.
31. HORNE, A.L. & KEMP, J.A. (1991). The effect of ω-conotoxin GVIA on synaptic transmission within the nucleus accumbens and hippocampus of the rat in vitro. Br. J. Pharmacol., 103, 1733-1739.
32. 2+ channels in freshly dissociated rat cerebellar Purkinje neurons by diltiazem and verapamil. Brain Res., 695, 88-91.
33. KAHLE, J.S. & COTMAN, C.W. (1993). Adenosine, L-AP4, and baclofen modulation of paired-pulse potentiation in the dentate gyrus: Interstimulus interval-dependent pharmacology. Exp. Brain Res., 94, 97-104.
34. KEW, J.N.C., TRUBE, G. & KEMP, J.A. (1996). A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J. Physiol., 497, 761-772.
35. KLEIN, M. & MUSACCHIO, J.M. (1989). High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. J. Pharmacol. Exp. Ther., 251, 207-215.
36. KLEIN, M. & MUSACCHIO, J.M. (1992). High-affinity dextromethorphan and (+)-3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine binding sites in rat brain. Allosteric effects of ropizine. J. Pharmacol. Exp. Ther., 260, 990-999.
37. LEANDER, J.D. (1989). Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice. Epilepsy Res., 4, 28-33.
38. LEANDER, J.D., RATHBUN, R.C. & ZIMMERMAN, D.M. (1988). Anticonvulsant effects of phencyclidine-like drugs: Relation to N-methyl-D-aspartic acid antagonism. Brain Res., 454, 368-372.
39. LÜCKE, A., KÖHLING, R. & SPECKMANN, E.-J. (1996). Effects of glutamate application on the rhythm of low magnesium-induced epileptiform activity in hippocampal slices of guinea-pigs. Eur. J. Neurosci., 8, 2137-2148.
40. 3H]D-aspartate release and neuronal calcium influx by verapamil, diltiazem and dextromethorphan: Evidence for non-L/non-N voltage-sensitive calcium channels. Eur. J. Pharmacol., 192, 9-17.
41. MCLARNON, J., SAWYER, D. & CHURCH, J. (1994). The actions of L-687,384, a σ receptor ligand, on NMDA-induced currents in cultured rat hippocampal pyramidal neurons. Neurosci. Lett., 174, 181-184.
42. MODY, I., LAMBERT, J.D.C. & HEINEMANN, U. (1987). Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J. Neurophysiol., 57, 869-888.
43. MORÓN, M.A., STEVENS, C.W. & YAKSH, T.L. (1990). The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat. J. Pharmacol. Exp. Ther., 252, 1150-1155.
44. MUSACCHIO, J.M., KLEIN, M. & SANTIAGO, L.J. (1988). High affinity dextromethorphan binding sites in guinea pig brain: Further characterization and allosteric interactions. J. Pharmacol. Exp. Ther., 247, 424-431.
45. NETZER, R., PFLIMLIN, P. & TRUBE, G. (1993). Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur. J. Pharmacol., 238, 209-216.
46. PARSONS, C.G., QUACK, G., BRESINK, I., BARAN, L., PRZEGALINSKI, E., KOSTOWSKI, W., KRZASCIK, P., HARTMANN, S. & DANYSZ, W. (1995). Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology, 34, 1239-1258.
47. POHL, M., STRAUB, H. & SPECKMANN, E.-J. (1992). Low magnesium-induced epileptiform discharges in guinea pig hippocampal slices: Depression by the organic calcium antagonist verapamil. Brain Res., 577, 29-35.
48. PONCER, J.-C., MCKINNEY, R.A., GÄHWILER, B.H. & THOMPSON, S.M. (1997). Either N- or P-type calcium channels mediate GABA release at distinct hippocampal inhibitory synapses. Neuron. 18, 463-472.
49. PONTECORVO, M.J., KARBON, E.W., GOODE, S., CLISSOLD, D.B., BOROSKY, S.A., PATCH, R.J. & FERKANY, J.W. (1991). Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Res. Bull., 26, 461-465.
50. POTIER, B., DUTAR, P. & LAMOUR, Y. (1993). Different effects of ω-conotoxin GVIA at excitatory and inhibitory synapses in rat CA1 hippocampal neurons. Brain Res., 616, 236-241.
51. 2+ channel (VSCC) antagonists ω-Aga-IVA and ω-CTX-MVIIC inhibit spontaneous epileptiform discharges in the rat cortical wedge. Brain Res., 643, 352-356.
52. ROGAWSKI, M.A. & PORTER, R.J. (1990). Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev., 42, 223-286.
53. 3H]dextrorphan binding sites in rat brain determined by quantitative autoradiography. J. Pharmacol. Exp. Ther., 277, 1823-1836.
54. TANCREDI, V., HWA, G.G.C., ZONA, C., BRANCATI, A. & AVOLI, M. (1990). Low magnesium epileptogenesis in the rat hippocampal slice: Electrophysiological and pharmacological features. Brain Res., 511, 280-290.
55. TORTELLA, F.C. & MUSACCHIO, J.M. (1986). Dextromethorphan and carbetapentane: Centrally acting non-opioid antitussive agents with novel anticonvulsant properties. Brain Res., 383, 314-318.
56. TORTELLA, F.C., PELLICANO, M. & BOWERY, N.G. (1989). Dextromethorphan and neuromodulation: Old drug coughs up new activities. Trends Pharmacol. Sci., 10, 501-507.
57. TORTELLA, F.C., WITKIN, J.M. & MUSACCHIO, J.M. (1988). A non-opioid antitussive with potent anticonvulsant properties in rats. Eur. J. Pharmacol., 155, 69-75.
58. TRUBE, G. & NETZER, R. (1994). Dextromethorphan: Cellular effects reducing neuronal hyperactivity. Epilepsia. 35(Suppl.5), S62-S67.
59. TURNER, D.A. (1990). Feed-forward inhibitory potentials and excitatory interactions in guinea-pig hippocampal pyramidal cells. J. Physiol., 422, 333-350.
60. WALKER, J.M., BOWEN, W.D., WALKER, F.O., MATSUMOTO, R.R., DE COSTA, B. & RICE, K.C. (1990). Sigma receptors: Biology and function. Pharmacol. Rev., 42, 355-402.
61. WANG, S.-J., LU, K.-T. & GEAN, P.-W. (1997). Inhibition of synaptic transmission and epileptiform activity in central neurones by fluspirilene. Br. J. Pharmacol., 120, 1114-1118.
62. WESTERHOFF, C.H.A., DOMANN, R. & WHITE, O.W. (1995). Inhibitory mechanisms in epileptiform activity induced by low magnesium. Pflügers Arch., 430, 238-245.
63. WHITTEMORE, E.R., ILYIN, V.I. & WOODWARD, R.M. (1997). Antagonism of N-methyl-D-aspartate receptors by σ site ligands: Potency, subtype-selectivity and mechanisms of inhibition. J. Pharmacol. Exp. Ther., 282, 326-338.
64. WU, L.-G. & SAGGAU, P. (1994). Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron, 12, 1139-1148.
65. YAMAMOTO, H., YAMAMOTO, T., SAGI, N., KLENEROVA, V., GOJI, K., KAWAI, N., BABA, A., TAKAMORI, E. & MOROJI, T. (1995). Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via σ 1 site. J. Neurosci., 15, 731-736.